Shlomo Koyfman, MD, discusses registry data on thyroid cancer and how data from the registry can improve practice for oncologists.
Shlomo Koyfman, MD, a radiation oncologist at the Cleveland Clinic, discusses registry data on thyroid cancer and how data from the registry can improve practice for oncologists.
Oncologists are beginning to think more about aggressive thyroid cancer and how histologies, such as tall cell and hobnail histologies, can recur locally and require multiple surgeries. In some cases, tumors cannot be surgically resected, and patients require radiation instead, says Koyfman.
At the 2019 American Society of Oncology (ASCO) Annual Meeting, an abstract on hobnail thyroid cancers was presented. Because hobnail is a more aggressive variant of thyroid cancer that does not respond well to radioactive iodine, a group of physicians at the Cleveland Clinic identified factors that contribute to recurrence and death in this patient population. They also identified which patients are considered high-risk and should be treated with radiation.
Koyfman states that this is a novel practice that will move the field in a good direction.
Anticipating Novel Options for the RAI-Refractory DTC Armamentarium
May 15th 2023In season 4, episode 6 of Targeted Talks, Warren Swegal, MD, takes a multidisciplinary look at the RAI-refractory differentiated thyroid cancer treatment landscape, including the research behind 2 promising systemic therapy options.
Listen
Cretostimogene Grenadenorepvec Shows High CR Rate in BCG-Unresponsive NMIBC
July 17th 2024Mark D. Tyson, II, MD, MPH, discussed treatment with cretostimogene grenadenorepvec in high-risk Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer with carcinoma in situ and data from the BOND-003 trial.
Read More
Phase 3 VERIFY Trial Investigates Rusfertide’s Potential in Polycythemia Vera
July 16th 2024In an interview, Aniket Bankar, MD, discussed the background, design, and goals of the phase 3 VERIFY trial of the hepcidin mimetic rusfertide for the treatment of patients with polycythemia vera.
Read More
Examining Breast Cancer Recurrence Detection Methods in a Community Oncology Setting
July 12th 2024In an interview with Targeted Oncology, Ali Duffens, MD, discussed findings from a study which investigated detecting breast cancer recurrence among women treated at Kaiser Permanente Northern California.
Read More